Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients.
Ongarj J. et al, (2024), Tuberculosis (Edinburgh, Scotland), 148
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.
Wajja A. et al, (2024), The Lancet. Infectious diseases, 24, 285 - 296
Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
Wajja A. et al, (2024), The Lancet Infectious Diseases, 24, e78 - e79
Healthy volunteer symptom profile following research bronchoscopy
Morrison H. et al, (2023), Interventional pulmonology, PA4628 - PA4628
Healthy volunteer experience following research bronchoscopy
Morrison H. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60